VETmAb Biosciences, Inc.

📍 San Diego, United States🗓 Founded 2022👥 4 employees
Biotechnology Research🌐 vetmab.bio
Website LinkedIn
VETmAb BIO is a veterinary biopharmaceutical company focused on developing monoclonal antibodies ("mAbs") to treat debilitating diseases in dogs and cats. While monoclonal antibodies have provided revolutionary treatments in humans, mAbs technology has been underdeveloped in veterinary medicine. At VETmAb BIO, we’re taking advantage of human-validated targets and designing them specifically for dogs and cats, thereby mitigating technical risk. By utilizing our proprietary technologies, we can explore potential treatments to address various unmet needs in veterinary medicine. Our team is comprised of experts who have decades of collective experience in mAb technology and animal health. Learn more: https://www.vetmab.bio/about/
0
Total investors
0
Early stage
0
Mid stage
0
Late stage
2022
Founded

Investors

0 investors
All
Early stage
Mid stage
Late stage
No investors in this category
Frequently asked questions
When was VETmAb Biosciences, Inc. founded?
VETmAb Biosciences, Inc. was founded in 2022.
What industry is VETmAb Biosciences, Inc. in?
VETmAb Biosciences, Inc. operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is VETmAb Biosciences, Inc. based?
VETmAb Biosciences, Inc. is headquartered in San Diego, United States.